The results showed a higher abundance of O-glycans in the CA125 antigen from the ovarian cancer cells, with higher expression of GalNAc and lower expression of Galβ1,3-GalNAc, compared to the amniotic fluid samples. The gene discussed is MUC16; the disease is ovarian carcinoma.